Genotoxicity of chromium compounds. A review.
This article reviews approximately 700 results reported in the literature with 32 chromium compounds assayed in 130 short-term tests, using different targets and/or genetic end-points. The large majority of the results obtained with Cr(VI) compounds were positive, as a function of Cr(VI) solubility and bioavailability to target cells. On the other hand, Cr(III) compounds, although even more reactive than Cr(VI) with purified nucleic acids, did not induce genotoxic effects in the majority of studies using intact cells. Coupled with the findings of metabolic studies, the large data-base generated in short-term test systems provides useful information for predicting and interpreting the peculiar patterns of Cr(VI) carcinogenicity.
De Flora
S
S
Institute of Hygiene and Preventive Medicine, University of Genoa, Italy.
Bagnasco
M
M
Serra
D
D
Zanacchi
P
P
D000818:Animals; D002273:Carcinogens; D002857:Chromium / Q000633:toxicity*; D006801:Humans; D009152:Mutagenicity Tests; D009153:Mutagens
D002273:Carcinogens; D009153:Mutagens; D002857:Chromium